Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Enhancing multifunctional drug screening via artificial intelligence
Junlin
Dong
abd,
Chenyang
Wu
abc,
Tianle
Lu
ab,
Shiyu
Wang
c,
Wenjin
Zhan
ac,
Marc
Xu
abc,
Bing
Wang
d,
Zhenquan
Hu
c,
Horst
Vogel
*aef and
Shuguang
Yuan
*acg
aThe Research Center for Computer-Aided Drug Discovery, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, Guangdong, China. E-mail: shuguang.yuan@cadd2drug.org
bUniversity of Chinese Academy of Sciences, Beijing, 100049, China
cAlphaMol Science Ltd, Allschwil, 4123, Switzerland
dShenzhen Key Laboratory of Drug Quality Standard Research, Shenzhen Institute of Drug Control, Shenzhen, 518057, Guangdong, China
eInstitute of Chemical Sciences and Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. E-mail: horst.vogel@epfl.ch
fFaculty of Pharmaceutical Sciences, Shenzhen University of Advanced Technology, Shenzhen, 518055, Guangdong, China
gChina Pharmaceutical University, Nanjing, 210009, Jiangsu, China
First published on 17th October 2025
Abstract
Correction for ‘Enhancing multifunctional drug screening via artificial intelligence’ by Junlin Dong et al., Digital Discovery, 2025, 4, 2012–2024, https://doi.org/10.1039/D5DD00082C.
The authors regret the mislabelling of the corresponding authors of the original article. Junlin Dong, Chenyang Wu, Tianle Lu and Shiyu Wang were all shown as being corresponding authors of the original article, which is inaccurate. Horst Vogel and Shuguang Yuan are the corresponding authors of the original work, and this has been reflected in the author list here.
The authors also regret the omission of the statement “Junlin Dong, Chenyang Wu, Tianle Lu and Shiyu Wang contributed equally to the work.”.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2025 |